Increased aldosterone among HIV-infected women with visceral fat accumulation
- PMID: 19770620
- PMCID: PMC2921849
- DOI: 10.1097/QAD.0b013e3283328d3b
Increased aldosterone among HIV-infected women with visceral fat accumulation
Abstract
Increased aldosterone has been associated with obesity and the metabolic syndrome in non-HIV-infected individuals, but aldosterone has not been investigated among HIV-infected patients with increased visceral adipose tissue (VAT). Twenty-four-hour urine aldosterone was assessed among age and BMI-matched HIV-infected women with increased VAT, HIV-infected women without increased VAT and healthy controls. Twenty-four hour urine aldosterone was higher in HIV-infected women with increased VAT and was associated with SBP, VAT and hemoglobin A1c. Increased aldosterone may contribute to the detrimental effects of excess visceral adiposity on blood pressure and glucose homeostasis among HIV patients.
Similar articles
-
RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.J Clin Endocrinol Metab. 2015 Aug;100(8):2873-82. doi: 10.1210/jc.2015-1461. Epub 2015 Jun 18. J Clin Endocrinol Metab. 2015. PMID: 26086328 Free PMC article. Clinical Trial.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Increased urinary aldosterone excretion is associated with subcutaneous not visceral, adipose tissue area in obese individuals: a possible manifestation of dysfunctional subcutaneous adipose tissue.Clin Endocrinol (Oxf). 2013 Oct;79(4):510-6. doi: 10.1111/cen.12083. Epub 2013 Apr 13. Clin Endocrinol (Oxf). 2013. PMID: 23106315
-
Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.Obesity (Silver Spring). 2008 Jan;16(1):179-83. doi: 10.1038/oby.2007.50. Obesity (Silver Spring). 2008. PMID: 18223632
-
The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis.Metab Syndr Relat Disord. 2014 Feb;12(1):31-42. doi: 10.1089/met.2013.0107. Epub 2013 Nov 12. Metab Syndr Relat Disord. 2014. PMID: 24219127 Review.
Cited by
-
RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.J Clin Endocrinol Metab. 2015 Aug;100(8):2873-82. doi: 10.1210/jc.2015-1461. Epub 2015 Jun 18. J Clin Endocrinol Metab. 2015. PMID: 26086328 Free PMC article. Clinical Trial.
-
Risk of coronary heart disease in patients with HIV infection.Nat Rev Cardiol. 2014 Dec;11(12):728-41. doi: 10.1038/nrcardio.2014.167. Epub 2014 Oct 21. Nat Rev Cardiol. 2014. PMID: 25331088 Review.
-
Heart fat in HIV: marker or mediator of risk?Curr Opin HIV AIDS. 2017 Nov;12(6):572-578. doi: 10.1097/COH.0000000000000414. Curr Opin HIV AIDS. 2017. PMID: 28796027 Free PMC article. Review.
-
The multifaceted mineralocorticoid receptor.Compr Physiol. 2014 Jul;4(3):965-94. doi: 10.1002/cphy.c130044. Compr Physiol. 2014. PMID: 24944027 Free PMC article. Review.
-
Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.Curr Hypertens Rep. 2015 Jul;17(7):52. doi: 10.1007/s11906-015-0567-8. Curr Hypertens Rep. 2015. PMID: 26068659 Review.
References
-
- Ingelsson E, Pencina MJ, Tofler GH, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation. 2007;116:984–992. - PubMed
-
- Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008;19:88–90. - PubMed
-
- Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355–362. - PubMed
-
- Dolan SE, Hadigan C, Killilea KM, et al. Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr. 2005;39:44–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK040561/DK/NIDDK NIH HHS/United States
- R01 DK059535-05/DK/NIDDK NIH HHS/United States
- NIH RO1 DK 59535/DK/NIDDK NIH HHS/United States
- R01 DK059535/DK/NIDDK NIH HHS/United States
- K24 DK064545-08/DK/NIDDK NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- K23 HL092792-01/HL/NHLBI NIH HHS/United States
- K24 DK064545/DK/NIDDK NIH HHS/United States
- NIH K24 DK064545/DK/NIDDK NIH HHS/United States
- K23 HL092792/HL/NHLBI NIH HHS/United States
- P30 DK040561-14/DK/NIDDK NIH HHS/United States
- NIH M01 RR01066-25S1/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical